Dynamic Technology Lab’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,370
| Closed | -$267K | – | 1282 |
|
|
2023
Q3 | $267K | Buy |
+2,370
| New | +$267K | 0.03% | 704 |
|
|
2023
Q2 | – | Sell |
-6,500
| Closed | -$658K | – | 1282 |
|
|
2023
Q1 | $658K | Buy |
+6,500
| New | +$658K | 0.06% | 529 |
|
|
2022
Q1 | – | Sell |
-3,434
| Closed | -$292K | – | 1365 |
|
|
2021
Q4 | $292K | Buy |
+3,434
| New | +$292K | 0.03% | 806 |
|
|
2020
Q4 | – | Sell |
-6,145
| Closed | -$591K | – | 1222 |
|
|
2020
Q3 | $591K | Buy |
+6,145
| New | +$591K | 0.1% | 372 |
|
|
2019
Q4 | – | Sell |
-10,188
| Closed | -$918K | – | 1192 |
|
|
2019
Q3 | $918K | Buy |
+10,188
| New | +$918K | 0.16% | 172 |
|
|
2019
Q1 | – | Sell |
-4,814
| Closed | -$343K | – | 1216 |
|
|
2018
Q4 | $343K | Sell |
4,814
-5,179
| -52% | -$369K | 0.06% | 575 |
|
|
2018
Q3 | $1.23M | Buy |
+9,993
| New | +$1.23M | 0.17% | 160 |
|
|
2018
Q2 | – | Sell |
-5,461
| Closed | -$453K | – | 1208 |
|
|
2018
Q1 | $453K | Buy |
+5,461
| New | +$453K | 0.07% | 526 |
|
|
2017
Q1 | – | Sell |
-11,601
| Closed | -$449K | – | 1159 |
|
|
2016
Q4 | $449K | Buy |
11,601
+2,991
| +35% | +$116K | 0.12% | 311 |
|
|
2016
Q3 | $437K | Buy |
+8,610
| New | +$437K | 0.12% | 303 |
|
|
2015
Q4 | – | Sell |
-6,000
| Closed | -$239K | – | 1028 |
|
|
2015
Q3 | $239K | Buy |
+6,000
| New | +$239K | 0.08% | 553 |
|
|
2014
Q1 | – | Sell |
-31,519
| Closed | -$294K | – | 694 |
|
|
2013
Q4 | $294K | Buy |
+31,519
| New | +$294K | 0.2% | 201 |
|